DUBLIN, Apr. 24, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/pmbmv2/global_biobanking) has announced the addition of the "Global Biobanking Market 2015-2019" report to their offering.
The analysts forecast the Global Biobanking market to grow at a CAGR of 7.07% over the period 2014-2019
The Global Biobanking market can be divided into two segments: Equipment and Consumables. This report covers the present scenario and the growth prospects of the Global Biobanking market for the period 2015-2019.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA. The human biobanks work by systematic collection of biological samples from patients and other members of the public. Biobanks significantly vary in size such as biobanks held in medical institutions hold relatively modest number of samples compared with a national biobank, which hold a large number of samples. Biobanks are commonly used to support research of most common types of genetic disorders, for developing personalized medicine, for stem cell research, and for maintaining and updating age demographic databases.
Strategic alliances between companies to collectively use technology and enhance their expertise in the Biobanking segment are a major trend in the market. Strategic alliances with manufacturers, the scientific community, and policy makers will enhance the development of best practice procedures for biobanks.
According to the report, advancement in technology in the field of personalized medicine is one of the major contributors to the growth of the market. Personalized medicine allows drugs to be developed according to the genetic makeup of a person. Biobanks store the data related to a person's genetic characteristics, which can be accessed by the scientist for research and drug discovery.
Further, the report states that lack of sustainability and bankruptcy leading to the closing down of several biobanks is an important challenge that the market faces. Numerous studies have shown that people's perception is positive when the research is carried out for study but is negative when commercial entities are involved.
- Beckman Coulter
- Thermo Fischer Scientific
Other Prominent Vendors
- Askion GmBH
- B&C Group
- BioRep SRL
- BioStorage Technologies
- Brooks Life Science Systems
- Cryo Bio System
- DNA Genotek
- LVL Technologies
- SOL Group
- Tissue Solutions
- Trans-Hit Biomarkers
- Wildcat Laboratory Solutions
For more information visit http://www.researchandmarkets.com/research/pmbmv2/global_biobanking
Media Contact: Laura Wood , +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets